Open Label Clinical Trial of Intravenous Crotoxin Part 3
NCT01481532
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Cancer
Interventions
DRUG:
Crotoxin
Sponsor
Celtic Biotech Ltd
Collaborators
[object Object]